Literature DB >> 4357887

In vivo inhibition of growth of two hormone-dependent mammary tumors by dibutyryl cyclic AMP.

Y S Cho-Chung, P M Gullino.   

Abstract

Growth of hormone-dependent rat mammary tumors was arrested in vivo by N(6),O(2)'-dibutyryl cyclic adenosine 3',5'-monophosphate. Estrogen concentration did not change, but acid ribonuclease activity and synthesis increased during treatment with the dibutyryl cyclic nucleotide, as was shown during tumor regression due to hormonal deprivation. Growth arrest, thus, appears to derive from enhanced tissue catabolism.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4357887     DOI: 10.1126/science.183.4120.87

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  6 in total

1.  Melanoma cells resistant to inhibition of growth by melanocyte stimulating hormone.

Authors:  J Pawelek; M Sansone; N Koch; G Christie; R Halaban; J Hendee; A B Lerner; J M Varga
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

2.  Treatment of intra-abdominal and abdominal wall desmoid tumors with drugs that affect the metabolism of cyclic 3',5'-adenosine monophosphate.

Authors:  W R Waddell
Journal:  Ann Surg       Date:  1975-03       Impact factor: 12.969

3.  Effect of sodium butyrate on mammalian cells in culture: a review.

Authors:  K N Prasad; P K Sinha
Journal:  In Vitro       Date:  1976-02

4.  Protamine inhibits adenylate cyclase activity: a possible reason for the toxicity of protamine.

Authors:  Z Kiss; R Zamfirova
Journal:  Experientia       Date:  1983-12-15

5.  Different growth responses to agents which elevate cAMP in human melanoma cell lines of high and low experimental metastatic capacity.

Authors:  E J Ormerod; I R Hart
Journal:  Clin Exp Metastasis       Date:  1989 Jan-Feb       Impact factor: 5.150

6.  Effect of sodium butyrate on synthesis of specific proteins by human breast-carcinoma cells.

Authors:  R J Grieve; K L Woods; P R Mann; S C Smith; G D Wilson; A Howell
Journal:  Br J Cancer       Date:  1980-10       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.